查看分析师 EPS 与营收区间、覆盖人数，以及过去 7、30、90 天的预期变化。缺失修正不会显示成零；分析师人数较少的公司默认不进入排名。
| 公司 | 财年 EPS | 预期区间 | 分析师 | 7 日 | 30 日 | 90 日 | 30 日上调 / 下调 | 营收预期 |
|---|---|---|---|---|---|---|---|---|
| THG Hanover Insurance Group Inc | 20.24 2026-12-31 | 19.59 – 20.77 | 5 | +9.50% | +8.86% | +9.40% | 8 / 0 | $6.67B |
| NOV NOV Inc. Common Stock | 0.86 2026-12-31 | 0.74 – 1 | 13 | +7.73% | +7.93% | +10.30% | 1 / 1 | $8.64B |
| CVE Cenovus Energy Inc Common Stock | 3.19 2026-12-31 | 3.04 – 3.31 | 3 | +5.48% | +7.78% | +13.26% | 0 / 1 | $59.8B |
| INVX Innovex International Inc. Common Stock | 1.42 2026-12-31 | 0.86 – 1.65 | 4 | +1.07% | +5.71% | +5.14% | 0 / 0 | $1.01B |
| ENVA Enova International Inc. Common Stock | 17.2 2026-12-31 | 16.99 – 17.41 | 4 | +5.07% | +5.07% | +5.13% | 5 / 0 | $3.72B |
| NVO Novo Nordisk A/S Common Stock | 21.77 2026-12-31 | 19.43 – 24.9 | 8 | -0.44% | +0.93% | -1.06% | 2 / 3 | $294.05B |
| BNS Bank Nova Scotia Halifax Pfd 3 Ordinary Shares | 8.3 2026-10-31 | 8.15 – 8.53 | 12 | -0.00% | +0.10% | +1.34% | 12 / 1 | $39.63B |
| NVMI Nova Ltd. Ordinary Shares | 10.49 2026-12-31 | 10.11 – 11.09 | 8 | +0.07% | +0.07% | +1.58% | 5 / 1 | $1.07B |
| LIVN LivaNova PLC Ordinary Shares | 4.25 2026-12-31 | 4.23 – 4.28 | 9 | -0.02% | +0.05% | +0.96% | 8 / 0 | $1.51B |
| ISSC Innovative Solutions and Support Inc. Common Stock | 0.92 2026-09-30 | 0.87 – 0.99 | 3 | 0.00% | 0.00% | +21.85% | 1 / 0 | $93.73M |
| NOVT Novanta Inc. Common Stock | 3.59 2026-12-31 | 3.55 – 3.62 | 3 | 0.00% | 0.00% | +0.75% | 2 / 1 | $1.05B |
| ONTO Onto Innovation Inc. Common Stock | 7.2 2026-12-31 | 7.01 – 7.4 | 10 | 0.00% | 0.00% | +1.71% | 7 / 0 | $1.34B |
| GEV GE Vernova Inc. Common Stock | 30.76 2026-12-31 | 26.83 – 33.23 | 22 | +0.24% | -0.05% | -0.76% | 1 / 0 | $46.21B |
| NVS Novartis AG Common Stock | 8.82 2026-12-31 | 8.61 – 9.04 | 7 | +1.12% | -0.15% | -2.05% | 1 / 2 | $57.58B |
| ENOV Enovis Corporation Common Stock | 3.64 2026-12-31 | 3.59 – 3.72 | 13 | -0.10% | -0.17% | +1.02% | 7 / 3 | $2.34B |
| FBIN Fortune Brands Innovations Inc. Common Stock | 3.12 2026-12-31 | 3.03 – 3.25 | 17 | -0.69% | -0.63% | -8.10% | 0 / 15 | $4.38B |
| HNVR Hanover Bancorp Inc. Common Stock | 2.36 2026-12-31 | 2.3 – 2.4 | 3 | -1.66% | -1.53% | -3.93% | 0 / 2 | $79.7M |
| AUR Aurora Innovation Inc. Class A Common Stock | -0.56 2026-12-31 | -0.76 – -0.45 | 4 | — | — | — | 1 / 0 | $15.01M |
| ENVX Enovix Corporation Common Stock | -0.56 2026-12-31 | -0.63 – -0.52 | 9 | — | — | — | 6 / 1 | $40.46M |
| IMVT Immunovant Inc. Common Stock | -2.53 2027-03-31 | -2.94 – -1.75 | 5 | — | — | — | 1 / 2 | $0 |
| NG Novagold Resources Inc. | -0.26 2026-11-30 | -0.34 – -0.13 | 5 | — | — | — | 0 / 2 | $0 |
| NKLR Terra Innovatum Global N.V. Ordinary shares | -0.17 2026-12-31 | -0.21 – -0.15 | 3 | — | — | — | 0 / 0 | $0 |
| NVAX Novavax Inc. Common Stock | -0.47 2026-12-31 | -1.38 – 0.52 | 9 | — | — | — | 1 / 6 | $409.97M |
| NVCR NovoCure Limited Ordinary Shares | -1.25 2026-12-31 | -1.39 – -1.05 | 7 | — | — | — | 2 / 4 | $725.82M |
| PRPL Purple Innovation Inc. Common Stock | -6.63 2026-12-31 | -8.25 – -5 | 4 | — | — | — | 2 / 0 | $470.45M |
| SI Shoulder Innovations Inc. Common Stock | -1.68 2026-12-31 | -1.73 – -1.63 | 3 | — | — | — | 1 / 1 | $67.28M |
默认至少 3 位分析师。没有历史值、EPS 非正值或历史 EPS 过于接近零时显示“—”，不会用失真的百分比参与排名。
榜单优先使用当前财年 EPS；营收修正由每日快照逐步积累，首日不会生成伪历史。